Lumbrokinase, 30 Delayed Release Vegicaps

Description

Lumbrokinase is an enzyme derived from earthworms Lumbricus rubellus. Research has shown lumbrokinase to support the body in breaking up and dissolving the unhealthy coagulation of blood and to enhance fibrinolytic activity, i.e. similar to nattokinase.

Lumbrokinase (LK) consists of a group of proteolytic enzymes including plasminogen activator and plasmin extracted from a specific species of earthworm. The plasminogen activator (e-PA) in LK is similar to tissue plasminogen activator (t-PA) from other sources, which makes it possible to show the thrombolytic activity only in the presence of fibrin. Therefore, LK has the advantage of not causing excessive bleeding. The activity of LK is much higher than most traditional Chinese medicines that are available in the United States. Four phases of clinical studies have been done on LK at the Beijing Xuanwu Hospital (the top hospital in nerve & internal medicine in China). LK has been widely used in over 100 hospitals in Beijing since 1995. In Jakarta, LK has been used in thousands of hospitals and drug stores in more than 20 provinces and cities as well as in Hong Kong, Taiwan, Southeast Asia, and Europe.

LK has a certificate of GMP for human drugs from the SDA in China and is recognized as a state class new drug approved by the Ministry of Public Health. LK capsules technology was awarded with a certificate of National Significance Achievement in Science and Technology listed as the Promotional project of National Key Technology Achievement and the National Torch Plan Program, and selected as National Key New product by 6 major ministries. It has been included in the Medicines Catalog of National Fundamental Health Insurance and awarded with gold prize at China’s Achievement in Medicine and Public Health Technology Fair.

Special Info

Use under medical supervision if taking anticoagulant drugs. Contraindicated in any condition associated with bleeding.